#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Heart Failure

We recommend srdce

Under the Microscope: How is Patient Care for Heart Failure in the Czech Republic in Real Practice?

18. 4. 2024 Source: Heart Failure

The journal Vnitřní lékařství recently published the results of a survey conducted among outpatient cardiologists and internists. The aim was to determine the level of diagnosis and treatment of patients with chronic heart failure (CHF) in real-life practice in the Czech Republic, with a special focus on the presence of symptoms in patients who have not yet been diagnosed. We briefly summarize the key findings from this survey.

srdce

ACC 2023 Expert Consensus: How to Optimize Diagnosis and Treatment of Heart Failure with Preserved EF LK

Heart failure (HF) remains a significant cause of morbidity and mortality, with the incidence and…
14. 3. 2024 Source: Heart Failure
srdce

Improving treatment outcomes of HF with preserved ejection fraction according to JACC: What does the success of gliflozins mean for the future?

The Journal of the American College of Cardiology (JACC) recently issued a scientific statement in…
4. 3. 2024 Source: Heart Failure

Articles on this topic
srdce

Cardio-renal-metabolic syndrome in context

The increase in the incidence of type 2 diabetes mellitus (T2DM), cardiovascular diseases (CVD),...
16. 1. 2024 Source: Heart Failure
srdce

How Important is the Time Factor in the Treatment of Heart Failure?

Current guidelines emphasize the importance of early diagnosis and immediate treatment for…
13. 11. 2023 Source: Heart Failure
kongres

The Latest Updates of ESC Recommendations for Heart Failure Treatment

What is new in heart failure therapy? At the annual congress of the European Society of…
18. 10. 2023 Source: Heart Failure
Tabelty diuretik

Do Gliflozins Affect the Need to Use Diuretics?

Sodium-glucose cotransporter 2 inhibitors (SGLT2i, i.e., gliflozins) have advanced from their…
1. 10. 2023 Source: Heart Failure
Měření ejekční frakce

Efficacy of Empagliflozin in HFpEF Patients – Comparison of Subpopulations with Preserved and Mid-Range LV EF

A sub-analysis of the EMPEROR-Preserved clinical trial examined the effects and safety of…
24. 8. 2023 Source: Heart Failure
Srdeční tlak

Analysis of Data from the EMPEROR-Preserved Study Revealed Whether Blood Pressure Affects the Effectiveness of Empagliflozin in Patients with Heart Failure with Preserved Ejection Fraction

Hypertension is among the most common etiological factors of heart failure with preserved…
19. 6. 2023 Source: Heart Failure
Empagliflozin

Empagliflozin will be funded from May for symptomatic heart failure regardless of EF LK value

Empagliflozin entered the market as an antidiabetic drug operating on the principle of…
14. 4. 2023 Source: Heart Failure
lékařka s pacientkou kardio

H₂FPEF Score for Estimating the Probability of Heart Failure with Preserved Ejection Fraction in Persons with Unexplained Dyspnea

The simple, validated H₂FPEF scoring system based on clinical and echocardiographic parameters,...
23. 3. 2023 Source: Heart Failure
srdce a diabetes

Diabetes mellitus and heart failure − interconnected units with complex pathogenesis

Diabetes mellitus (DM) represents a significant risk factor for the development of heart…
12. 1. 2023 Source: Heart Failure
nemocnice příjem čekárna

Prevalence of Heart Failure and Its Subtypes in the Population of Developed Countries

In developed countries, heart failure occurs in approximately 2% of the population, with an…
2. 1. 2023 Source: Heart Failure

1 2 3 4
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#